Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer
The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1014731.htm
- Syndication ID: 19832
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:16 PM
- Date Syndication Updated: Wednesday, September 02, 2020 at 09:12 AM
Tags
General:
HRT
hormone therapy
estrogen
ovarian cancer
hormone replacement therapy
postmenopausal symptoms
survival
institute for cancer research
adjuvant therapy
women’s health initiative
Embed Code Snippet
To get the embed code snippet please Login.
